Health

Leading the Fight of Emerging Diseases

Making “one bug, one drug” a thing of the past

Making “one bug, one drug” a thing of the past

By carstories

With the expertise of the Baric Lab at the UNC Gillings School of Global Public Health, Gilead Sciences is making breakthroughs in developing drugs to fight some of the world’s deadliest pathogenic viruses like MERS, SARS and Ebola.

In the past, the approach was “one bug, one drug” — using a drug or vaccine specific to a disease. Now, a broad-spectrum antiviral — working against a large variety of highly pathogenic viruses — potentially holds the key to pandemic preparedness and the power to control future outbreaks.

Read the complete Carolina Story…Opens in new window

This is story number 118 in the Carolina Stories 225th Anniversary Edition magazine.
 

.

UNC Gillings School of Global Public Health Funding Priorities

    Readers Also Viewed...

    Rebecca Fry leans agains a shelf in the Fry Lab.
    Faculty Support

    Angling for Solutions

    Rebecca Fry’s lab is one of the first to study the effects of prenatal exposure to toxic metals as it relates to the epigenome.

    Portrait of Dean Nancy Messionnier
    Faculty Support

    Honored for Advancement of Medical Sciences

    Dean Nancy Messonnier inducted into the National Academy of Medicine

    Elderly women participate in an exercise class
    Health

    Moving Toward Better Cognition

    New project seeks to pilot greater physical activity for older adults

    Health

    Showing Teens the Real Cost

    Carolina researchers find that Real Cost anti-vaping ads are effective at discouraging youth from vaping

    Portrait of Danyu Lin
    Research

    Crucial Study for Child COVID

    New research makes the case for children’s COVID boosters

    A doctor performs a sonograph
    Global Impact

    Making Ultrasounds Universal

    Using the power of artificial intelligence to improve maternal health worldwide